Effect of mTOR Inhibition & Other Metabolism Modulating Interventions on the Elderly [SubStudy Rapa & cMRI to Evaluate Cardiac Function]

PHASE2CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

February 1, 2022

Primary Completion Date

September 9, 2025

Study Completion Date

September 9, 2025

Conditions

Aging

Interventions

DRUG

rapamycin

Taken orally 1mg daily for 8 weeks

Trial Locations (2)

Audie L. Murphy Memorial Veterans Hospital, San Antonio

The University of Texas Health Science Center at San Antonio, San Antonio

All Listed Sponsors

collaborator

The Claude D. Pepper Older Americans Independence Centers

OTHER

collaborator

National Institute on Aging (NIA)

NIH

lead

The University of Texas Health Science Center at San Antonio

OTHER